Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Adenosine adverse reaction |
Causative agent (attribute) |
True |
Adenosine |
Inferred relationship |
Some |
1 |
adénosine 3 mg/mL, flacon de 2 mL de solution pour injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Adenosine |
Inferred relationship |
Some |
|
adénosine 3 mg/mL, flacon de 10 mL de solution pour injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Adenosine |
Inferred relationship |
Some |
|
Adenosine 3mg/mL injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Adenosine |
Inferred relationship |
Some |
|
Product containing adenosine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Adenosine |
Inferred relationship |
Some |
1 |
Allergy to adenosine |
Causative agent (attribute) |
False |
Adenosine |
Inferred relationship |
Some |
|
Adenosine 3mg/mL injection solution 20mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Adenosine |
Inferred relationship |
Some |
|
Adenosine 3mg/mL injection solution 4mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Adenosine |
Inferred relationship |
Some |
|
Adenosine 3mg/mL injection solution 30mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Adenosine |
Inferred relationship |
Some |
|
Cardiovascular stress test using the adenosine stress test protocol (procedure) |
Using substance (attribute) |
False |
Adenosine |
Inferred relationship |
Some |
1 |
Cardiovascular stress test using the adenosine stress test protocol (procedure) |
Using substance (attribute) |
True |
Adenosine |
Inferred relationship |
Some |
1 |
Adenosine 3mg/mL injection solution 2mL prefilled syringe |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Adenosine |
Inferred relationship |
Some |
|
Adenosine 3mg/mL injection solution 4mL prefilled syringe |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Adenosine |
Inferred relationship |
Some |
|
Allergy to adenosine |
Causative agent (attribute) |
True |
Adenosine |
Inferred relationship |
Some |
1 |
Product containing precisely adenosine 30 milligram/10 milliliter conventional release solution for infusion vial |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Adenosine |
Inferred relationship |
Some |
1 |
Product containing precisely adenosine 30 milligram/10 milliliter conventional release solution for infusion vial |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Adenosine |
Inferred relationship |
Some |
1 |
Product containing precisely adenosine 6 milligram/2 milliliter conventional release solution for injection vial |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Adenosine |
Inferred relationship |
Some |
1 |
Product containing precisely adenosine 6 milligram/2 milliliter conventional release solution for injection vial |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Adenosine |
Inferred relationship |
Some |
1 |
Succinyladenosine |
This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. |
True |
Adenosine |
Inferred relationship |
Some |
|
Adenosine-containing product in parenteral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Adenosine |
Inferred relationship |
Some |
1 |
Product containing only adenosine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Adenosine |
Inferred relationship |
Some |
1 |
Adenosine only product in parenteral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Adenosine |
Inferred relationship |
Some |
1 |
Deoxy adenosine diphosphate |
This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. |
True |
Adenosine |
Inferred relationship |
Some |
|
Cyclic adenosine monophosphate |
This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. |
True |
Adenosine |
Inferred relationship |
Some |
|
Adenosine diphosphate |
This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. |
True |
Adenosine |
Inferred relationship |
Some |
|
Nephrogenous cyclic AMP |
This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. |
True |
Adenosine |
Inferred relationship |
Some |
|
Adenosine phosphate (substance) |
This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. |
True |
Adenosine |
Inferred relationship |
Some |
|
Deoxyadenylic acid |
This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. |
True |
Adenosine |
Inferred relationship |
Some |
|
Adenylic acid |
This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. |
True |
Adenosine |
Inferred relationship |
Some |
|
Adenosine triphosphate |
This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. |
True |
Adenosine |
Inferred relationship |
Some |
|
Collagen ADP |
This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. |
True |
Adenosine |
Inferred relationship |
Some |
|
Adenosine 3 mg/mL solution for infusion |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Adenosine |
Inferred relationship |
Some |
1 |
Adenosine 3 mg/mL solution for infusion |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Adenosine |
Inferred relationship |
Some |
1 |
Product containing precisely adenosine 3 milligram/1 milliliter conventional release solution for injection (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Adenosine |
Inferred relationship |
Some |
1 |
Product containing precisely adenosine 3 milligram/1 milliliter conventional release solution for injection (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Adenosine |
Inferred relationship |
Some |
1 |
Product containing precisely adenosine 3 milligram/1 milliliter conventional release solution for infusion and/or injection (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Adenosine |
Inferred relationship |
Some |
1 |
Product containing precisely adenosine 3 milligram/1 milliliter conventional release solution for infusion and/or injection (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Adenosine |
Inferred relationship |
Some |
1 |